Skip to main content
Premium Trial:

Request an Annual Quote

Genomatica Awarded Phase II SBIR for Cellular Simulation Technology

NEW YORK, Nov. 4 (GenomeWeb News) - Computational systems biology startup Genomatica has received a two-year, $765,000 Phase II Small Business Innovation Research grant from the National Human Genome Research Institute to support development of its cellular simulation technology platform.

The company said it would use the award to integrate high-throughput experimental data, such as gene expression information, with its computer models of cellular metabolism.

Christophe Schilling, CTO of Genomatica and principal investigator for the grant, said that under the first phase of the SBIR, the company demonstrated the use of its models of cellular metabolism to predict gene expression patterns in yeast. The Phase II effort will illustrate "the use of computational metabolic models for the visualization, analysis, and integration of gene expression data," he said.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.